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Abstract
Retinoids are recognized as important regulators of vertebrate development, cell differentiation,
and tissue function. Previous studies, performed both in vivo and in vitro, indicate that retinoids
influence several reproductive events, including follicular development, oocyte maturation and
early embryonic development. The present study evaluated in vitro effects of retinol addition to
media containing maturing bovine oocytes and developing embryos in both a low oxygen
atmosphere (7%) and under atmospheric oxygen conditions (20%). In the first experiment, abbatoir
collected bovine oocytes were matured in the presence or absence of varying concentrations of
retinol. After a 22–24 hour maturation period the oocytes were fertilized, denuded 18 hours later
and cultured in a modified synthetic oviductal fluid (mSOF) in a humidified atmosphere at 38.5
degrees C, 5% CO2, 7% O2 and 88% N2. Cleavage rates did not differ among control and retinol-
treated oocytes in all three experiments. Addition of 5 micromolar retinol to the maturation
medium (IVM) tended (p < 0.07) to increase blastocyst formation (blastocyst/putative zygote;
26.1% +/- 2.2%) compared to the controls (21.9% +/- 1.9%). Further analysis revealed when
blastocyst development rates fell below 20% in the control groups, 5 micromolar retinol treatment
dramatically improved embryonic development, measured by blastocyst/putative zygote rate (14.4
+/- 2.1 vs 23.7 +/- 2.5; p < 0.02). The 5 micomolar retinol treatment also enhanced the blastocyst/
cleaved rate by nearly 10% (23.7% vs 34.6%; p < 0.02). In the second and third experiments addition
of 5 micromolar retinol to the embryo culture medium (IVC) under low oxygen conditions did not
significantly improve cleavage or blastocyst rates, but 5 micromolar retinol significantly increased
blastocyst development under 20% O2 conditions (p < 0.001). These studies demonstrate that
supplementation of 5 micromolar retinol to the maturation medium may improve embryonic
development of bovine oocytes indicated by their increased blastocyst rate. A significant
improvement in the blastocyst development with the 5 micromolar retinol treatment under
atmospheric conditions suggests a beneficial antioxidant effect during embryo culture.
Background
Vitamin A is essential for reproduction, and deficiencies
and excesses may result in embryonic loss and/or congen-
ital defects [1]. Retinol (vitamin A alcohol) is the parent
vitamin A compound and metabolites, analogs, and
derivatives are known collectively as retinoids. Results
from several studies, in a variety of species, have indicated
that retinoid administration may function in very early
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events associated with reproductive success, including fol-
licular development, oocyte maturation and early embry-
onic development. Retinol concentration in bovine
follicular fluid was shown to be an indicator of follicular
quality and was highest in healthy follicles, lowest in
atretic follicles and highly correlated with estradiol con-
centrations [2,3]. Retinol or β-carotene administration
has been shown to prevent fetal resorption in rats [4],
increase the number of births in rabbits [5], and increase
litter size in swine [6]. Retinol administration to ewes, in
combination with superovulation followed by natural
service was shown to improve the competence of resultant
1–4 cell and morula stage embryos, collected from the
oviduct and uterus, respectively, to develop to the blasto-
cyst stage when cultured in vitro [7]. In cattle, retinol
injection improved the estimated quality of embryos col-
lected from superovulated animals but did not increase
the number recovered [8].
Retinol is transported systemically and intercellularly
bound to retinol-binding protein (RBP). Cellular retinol-
binding proteins (CRBP) and cellular retinoic acid-bind-
ing proteins function in intracellular vitamin A transport,
metabolism and homeostasis [9]. All-trans and 9-cis retin-
oic acid (RA) are natural cellular metabolites of retinol
and mediate biological activity through interaction with
nuclear retinoic acid receptors (RAR) and retinoid X recep-
tors (RXR), respectively. Ligand-bound RARs and RXRs
influence transcription by interacting with response ele-
ments in the promoter regions of retinoid-regulated genes
[10]. Within the ovary, RBP and CRBP are expressed in
thecal and granulosa cells, and facilitate the transport of
retinol from the blood into developing follicles [3]. Con-
centrations of RBP, and its ligand retinol, are highest in
the follicular fluid of large preovulatory bovine ovarian
follicles, compared to smaller and/or atretic follicles [3].
RBP synthesis and secretion increase in the oviduct and
uterus coincident with the transport of the egg or embryo
into these organs [11,12].
The cumulus oocyte complex (COC) may be a target for
retinol, since the cells that nurture and communicate with
the oocyte, contain transcripts and protein for several
RARs and RXRs, RBP and retinaldehyde-2 dehydrogenase
(RALDH-2) a metabolizing enzyme [13]. Bovine oocytes
and embryos from the 2-cell to hatched blastocyst stage,
also express transcripts for several RARs, RXRs, RBP and
RALDH-2, and the inner cell mass and trophectoderm of
blastocysts express immunoreactive protein for RAR and
RXR [14]. It has been shown recently that addition of 9-cis
RA to in vitro oocyte maturation medium affects trophec-
toderm differentiation, total cell number and inner cell
mass-trophoblast cell ratios, following fertilization in cat-
tle oocytes [15,16]. Together, these studies suggest that the
reproductive tract delivers retinol to the oocyte and early
embryo which possess key elements of retinoid metabo-
lizing and signaling mechanisms; thus, influencing gene
expression, differentiation, and development.
The mechanism by which retinol or retinoic acid admin-
istration influences oocyte maturation and positively
impacts early embryonic development is not known and
is the subject of much investigation. Retinoic acid may
influence oocyte maturation through its effects on FSH or
LH receptor expression as demonstrated in porcine [17]
and rat [18] granulosa cells. Alternatively, it has been sug-
gested that retinoic acid may increase mRNA quality and
processing during maturation mediated by increases in
polyadenylation [19]. Expression of several growth factors
is influenced by RA [20]. Midkine [16], a member of the
heparin-binding growth/differentiation family, is induced
by RA and has been shown to improve bovine oocyte and
embryonic developmental competence [21]. In addition,
retinoids may promote development through participa-
tion in an endogenous oxidative-stress protection mecha-
nism [22].
In the present study, we investigated the effects of retinol
administration to in vitro matured oocytes, and cultured
bovine embryos under atmospheric O2 and reduced O2
conditions. Results suggest beneficial effects of retinol
administration during maturation especially to less com-
petent oocytes, and improved development of embryos
cultured under atmospheric oxygen conditions, indicating
protection from oxidative stress.
Materials and Methods
Reagents and Media
All chemicals were purchased from Sigma Chemical Com-
pany, St. Louis, MO unless otherwise noted. Bovine
oocyte collection medium (OCM) was composed of mod-
ified M199, 4.2 mM NaHCO3, 12 mM HEPES, and sup-
plemented with 2 mM glutamine, 2% fetal bovine serum
(FBS, BioWhittaker, Baltimore, MD), and penicillin/strep-
tomycin (Specialty Media, Phillipsburg, NJ). Oocyte mat-
uration medium (OMM) consisted of bicarbonate
buffered TCM-199 supplemented with 50 µg/mL of gen-
tamycin, purchased from Specialty Media, 5 µg/mL of FSH
purchased from Vetrepharm Canada, Inc. (Ontario, Can-
ada), 0.3 µg/mL of luteinizing hormone (LH) that was
generously provided by the USDA, Beltsville, MD, 10%
FBS, 0.2 µM sodium pyruvate and 2 mM glutamine. Mod-
ified Tyrode's Albumin Lactate Pyruvate (TALP) media
used in sperm preparation (SP-TALP), removal of cumu-
lus cells from oocytes (HEPES-TALP) and in vitro fertiliza-
tion (IVF-TALP) were prepared as described by Parrish et
al. [29]. In vitro culture (IVC) medium was a modified
synthetic oviductal fluid (mSOF) [30] supplemented with
3 mg/mL of BSA, 0.6 mM sodium pyruvate, 2% (v/v) BME
essential amino acids, 1% (v/v) MEM non-essential
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amino acids, and 100 µg/mL of penicillin and
streptomycin.
All-trans retinol was dissolved in 100% ethanol, appropri-
ate dilutions made, and aliquots were stored at -80°C
until use. Retinol was prepared fresh each month and
checked on a spectrophotometer for accuracy. The con-
centration of ethanol during maturation or culture was
less than 0.1%.
Collection and in vitro maturation (IVM) of oocytes
Ovaries from mature, cycling cattle were obtained from an
abbatoir and pooled. Cumulus oocyte complexes (COCs)
were quickly harvested by slicing follicles (2–5 mm) with
a sterile surgical blade, and collecting them in OCM.
Intact COCs with homogeneous ooplasm and two or
more layers of cumulus cells were selected, washed, and
approximately 50 were transferred to 500 µl of pre-equil-
ibrated OMM, and matured for 22–23 hours in a 38.5°C
incubator with an atmosphere of 5.0% CO2, ambient air,
and saturated humidity.
In vitro fertilization (IVF)
Fertilization (Day 0) was performed with combined
semen from two bulls of proven fertility prepared accord-
ing to the method by Parrish and coworkers [29]. Briefly,
spermatozoa were washed in a discontinuous Percoll gra-
dient (45%/90%) by depositing semen on top of the Per-
coll layers and centrifuged for 15 minutes at 960 g. The
pellet was removed and resuspended in SP-TALP and cen-
trifuged for 8 minutes at 460 g. After removal of the super-
natant, the sperm sample was reconstituted in 500 µL of
IVF-TALP for a final concentration of 1 × 106 spermato-
zoa/mL. The plate was incubated for 22 hours at 38.5°C
in an atmosphere of 5.0% CO2 and ambient air with satu-
rated humidity.
In vitro culture (IVC)
Approximately 18 hours after fertilization putative
zygotes were denuded of cumulus cells by vortexing in
500 µl of HEPES-TALP for four minutes (Day 1). Putative
zygotes (approximately 35–40) were cultured in 500 µL of
mSOF for eight days in a 38.5°C incubator in an atmos-
phere of 5% CO2, 7% O2 and 88% N2 (first and second
experiments) with saturated humidity. The mSOF
medium was changed every 48 hours. Cleavage was
assessed on Day 3 and blastocyst rate was calculated on
Day 8.
Experimental Design
In the first experiment maturation medium alone was
supplemented with all-trans retinol (0, 1.0, 5.0, or 10.0
µM) and embryos were allowed to develop under low oxy-
gen conditions. In the second experiment all-trans retinol
was added only to embryo culture medium (0, 1.0, 2.0,
5.0, or 10µM) on days 1, 3, 5, and 7, and the embryos
developed in a low oxygen atmosphere. In the third exper-
iment embryos were cultured under atmospheric oxygen
conditions (air and 5% CO2) and all-trans retinol (0 or
5µM) was added to embryo culture medium on days 1, 3,
5, and 7.
Data Analysis
Data were analyzed as an incomplete block design (exper-
iments 1, 2, and 3), or a randomized block design (exper-
iment 4), blocked on plate using mixed model procedures
of SAS [31]. At least six replicates were completed for each
experiment. Fisher's protected least significant differences
were used for separating least square differences for exper-
iments 1, 2, 3, and a two-tailed Student's T-test was per-
formed on data from experiment 4. Least square means ±
S.E.M. are expressed as the proportion of putative zygotes.
All data were subjected to a normality test (Shapiro-Wilk,
> 0.90) and were found to be normally distributed.
Results
In the first experiment addition of 5µM retinol during
IVM tended to improve (p < 0.07) embryonic develop-
ment to the blastocyst stage, compared to controls (Table
1). The control blastocyst rate was 21.9% compared to
26.1% in 5µM retinol. Addition of 1µM retinol to the mat-
uration medium did not appear to affect embryonic devel-
opment compared to controls. Retinol (10µM) increased
blastocyst development, although not significantly.
Cleavage rates did not differ among the four maturation
treatments.
Table 1: Effect of all-trans retinol addition to bovine oocyte maturation medium (mean ± S. E. M.). Embryos were cultured under low 
oxygen conditions.
Retinol concentration (µM) Putative zygote (n) Cleavage Blastocyst/ putative zygote Blastocyst/ cleaved
0 1095 66.7 ± 2.7 21.9 ± 1.9a 32.8 ± 2.2a
1.0 464 65.5 ± 3.9 20.4 ± 2.6a 31.7 ± 3.1a
5.0 1069 68.3 ± 3.2 26.1 ± 2.2b 37.1 ± 2.5b
10.0 508 70.1 ± 3.9 24.2 ± 2.7ab 33.8 ± 3.1ab
Values are listed as percentages. abMeans in the same column with different superscripts approach significance (p < 0.07).
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Further analysis of the maturation data (Table 2) revealed
that when development to the blastocyst stage of controls
was below 20%, 5µM retinol dramatically improved (p <
0.02) embryo development (14.4 % vs. 23.7%). When
expressed as blastocyst/cleaved the 5µM retinol treatment
also showed a significant improvement in blastocyst
development (p < 0.02). Neither 1µM nor 10µM retinol
treatment improved embryonic development when com-
pared to those controls that did not achieve a 20% blasto-
cyst rate.
Further experiments were conducted during IVC under
both low and atmospheric oxygen tensions. Under low
oxygen conditions concentrations of 1, 2, and 5µM retinol
were not statistically different from controls, and 10µM
was deleterious (Table 3). Preliminary dose-response
studies were performed under atmospheric conditions
(data not shown), and additional experiments were con-
tinued with the 5µM retinol treatment. Under atmos-
pheric oxygen conditions the 5µM concentration
significantly improved blastocyst development compared
to controls (p < 0.001) (Table 4). Cleavage rates did not
differ significantly among embryos treated with and with-
out retinol during culture under low or high oxygen
(Tables 3 &4). Fertilization rates did not differ signifi-
cantly among all experiments (data not shown).
Discussion
In the present study, over 3000 bovine oocytes were used
to evaluate effects of retinol supplementation during IVM
and IVC on embryonic development to the blastocyst
stage. Retinol administration during the maturation
period alone resulted in concentration-dependent effects.
Whereas the presence of 1µM retinol had no effect on
development, 5µM retinol tended to improve blastocyst
rate of development, at the p < 0.07 level, compared to
controls. At a concentration of 10µM, retinol did not sig-
nificantly improve embryo development compared to
Table 2: Effect of all-trans retinol addition to bovine oocyte maturation medium on embryo development among replicate groups 
where less than 20% of control embryos reached the blastocyst stage (mean ± S. E. M.).
Retinol concentration (µM) Putative zygote (n) Cleavage Blastocyst/ putative zygote Blastocyst/ cleaved
0 516 62.7 ± 3.9 14.4 ± 2.1a 23.7 ± 2.6a
1.0 185 60.0 ± 6.0 15.9 ± 3.4ab 26.1 ± 4.2ab
5.0 530 65.9 ± 4.6 23.7 ± 2.5b 34.6 ± 3.1b
10.0 183 63.3 ± 6.7 17.6 ± 3.8ab 26.7 ± 4.6ab
Values are listed as percentages. abMeans in the same column with different superscripts were significantly different (p < 0.02).
Table 3: Effect of all-trans retinol addition to the culture medium (mean ± S. E. M.). Embryos were cultured under low oxygen 
conditions.
Retinol concentration (µM) Putative zygote (n) Cleavage Blastocyst/ putative zygote Blastocyst/ cleaved
0 567 86.1 ± 2.5 26.5 ± 2.4a 30.7 ± 2.6a
1.0 312 84.7 ± 3.2 27.1 ± 3.2ab 32.1 ± 3.5a
2.0 414 85.3 ± 2.9 28.8 ± 2.8a 34.1 ± 3.1a
5.0 303 80.8 ± 3.2 20.2 ± 3.2a 25.4 ± 3.5a
10.0 388 81.2 ± 3.0 13.5 ± 3.0c 16.2 ± 3.3b
Values are listed as percentages. abcMeans in the same column with different superscripts were significantly different (p < 0.05).
Table 4: Effect of all-trans retinol addition to the culture medium (mean ± S. E. M.). Embryos were cultured under atmospheric oxygen 
conditions.
Retinol concentration (µM) Putative zygote (n) Cleavage Blastocyst/ putative zygote Blastocyst/ cleaved
0 400 73 ± 4.6 14 ± 2.3a 19.2 ± 3.2a
5.0 400 74 ± 1.5 28.8 ± 3.0b 38.9 ± 3.9b
Values are listed as percentages. abMeans in the same column with different superscripts were significantly different (p < 0.001).
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controls. In preliminary studies, higher concentrations
(100µM) were observed to be cytotoxic (data not shown).
Similarly, exposure of bovine oocytes to low
concentrations of 9-cis retinoic acid was shown to
improve subsequent blastocyst development but high
concentrations were detrimental [16].
A more striking effect on embryonic development (p <
0.02) was observed by supplementation of 5 µM retinol to
groups of oocytes with reduced developmental compe-
tence in which development of control oocytes to blasto-
cyst was less than 20%. These results indicate that retinol
supplementation during maturation may not benefit
oocytes competent to progress, but rather, it improves the
viability of oocytes that are developmentally challenged.
In support of this, we have shown previously that retinol
supplementation during maturation improves develop-
mental competence of bovine oocytes compromised by
heat stress [32].
Since most transcription in the oocyte occurs prior to mat-
uration during preovulatory development, in vitro culture
deprives oocytes of much of this activity. Meiotic inhibi-
tors have been used as a potential means of investigating
regulation of oocyte transcription and mRNA processing
in vitro [33]. Treatment of cumulus-enclosed oocytes with
9-cis RA during meiotic arrest was observed to improve
cortical granule migration, increase subsequent blastocyst
development and increase total cell number [34]. Gomez
and co-workers [19] suggested that retinoid administra-
tion may improve mRNA quality based on the observa-
tion that 9-cis RA increased poly-(A) mRNA content in
meiotically arrested oocytes. Poly-(A) mRNA content of
oocytes treated with 9-cis RA or ethanol vehicle was
greater in matured oocytes than in oocytes prematured in
the presence of 9-cis RA and then matured.
Retinol supplementation of embryo culture medium dra-
matically improved development to the blastocyst stage
(p < 0.001) when cultured in an atmosphere of approxi-
mately 20% O2 (air and 5% CO2) but not in an atmos-
phere of low O2 (7% O2, 5% CO2 and 88% N2). The
present study, and all previous in vitro studies demon-
strating a positive effect of retinoid administered during
maturation, were performed in an atmosphere of approx-
imately 20% O2 [15,16,34], a practice common to most
laboratories. Together, these data indicate that retinoids
may protect embryos from oxidative damage, which has
been identified as a leading cause of embryonic wastage,
especially in vitro [22].
Mammalian cells, including the oocyte and those of the
early embryo, have evolved several mechanisms to protect
against ROS damage and maintain appropriate balances
in REDOX reactions. Antioxidants present in the oocyte,
embryo and/or its environment include vitamins A (reti-
nol), C and E, pyruvate, glutathione (GSH), hypotaurine,
taurine, and cysteamine [22]. Antioxidant enzymes pro-
duced by oocytes and embryos include, copper, zinc
superoxide dismutase (Cu, Zn-SOD), manganese-SOD
(Mn-SOD), glutathione peroxidase (GPX), glutamyl
cysteine synthase (GCS), glutathione reductase (GR), cat-
alase and others [22]. Lonergan and co-workers [36] have
shown that expression of several antioxidant enzymes are
up-regulated during in vitro oocyte maturation compared
to in vivo maturation indicating that the former environ-
ment creates oxidative stress and oocytes respond by acti-
vating internal defense mechanisms. Addition of
antioxidants to culture medium or culture of embryos in
an atmosphere of reduced O2 has been demonstrated to
be beneficial to in vitro survival of embryos from a variety
of species [22].
Retinoids participate in a biological antioxidant network,
and have been implicated as important regulators of
redox signaling pathways [23,24]. Carotenoids and reti-
nol can quench single oxygen molecules and interact with
other antioxidant compounds [23]. Retinoic acid has
been shown to protect against oxidative stress-induced
apoptosis by inhibition of the c-jun N-terminal kinase
(JNK) activator protein 1 (AP-1) pathway in glomerular
[26] and mesangial cells [37]. In addition, anti-apoptotic
effects of RA were mediated by both nuclear receptor-
dependent and independent pathways [37].
Retinoids may also protect against oxidative damage by
maintaining adequate endogenous levels of antioxidant
compounds and enzymes. Glutathione is the major non-
protein sulphydryl compound found in mammalian cells
responsible for strong basal ROS scavenging activity [35].
Maintenance of adequate GSH levels is essential for
oocyte maturation, fertilization and embryonic develop-
ment [22]. Retinoic acid inhibited staurosporine-induced
GSH depletion in neuronal cells, preventing oxidative
damage and apoptosis [25]. A retinoic acid response ele-
ment (RARE) has been identified in the promoter region
of a specific isoform of glutathione S-transferase-pi
(GSTp) in glioblastoma cells [38] and GPX2 [28], an
enzyme necessary for the conversion and utilization of
GSH. RA has also been shown to significantly increase sur-
vival, reduce ROS content and increase protein levels of
Cu-Zn SOD and Mn-SOD in neuronal cells treated with
staurosporine [27]. Recently, microarray analysis revealed
that three genes which encode enzymes involved in GSH
synthesis and utilization were RXRα-target genes in
mouse liver [39]. The same study showed that in
hepatocytes of RXRα-deficient mice there was a significant
reduction in GSH synthesis rate and GSH content [39].
Together, these data provide strong evidence that in sev-
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eral cell systems, retinoids support and improve endog-
enous antioxidant defense mechanisms.
Conclusions
Results from the present study indicate that retinol
administration during in vitro maturation particularly
improved embryonic development in those oocytes that
may have been developmentally compromised. Moreo-
ver, retinol addition during in vitro culture, under atmos-
pheric conditions, also improved embryonic
development compared to those embryos incubated in a
7% oxygen atmosphere. The mechanisms by which retin-
oids affect the developmental capacity of oocytes and
early embryos may include modulation of expression of
growth factors and other developmental genes, improving
mRNA quality, and direct and/or indirect affects on anti-
oxidant defense mechanisms.
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